Partner News | Published: Thursday, September 17, 2026
The Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model is a 10-year national test launched by the Centers for Medicare & Medicaid Services (CMS) Innovation Center. It runs from July 5, 2026 through June 30, 2036, and it tests a genuinely different question than most Medicare payment programs: can paying for outcomes, rather than paying for specific services or devices, actually improve how chronic disease is managed at scale?
For years, U.S. healthcare reform has cycled through pilots, demonstrations and acronym-heavy experiments that promised to make care more coordinated, efficient and equitable. Many produced lessons, while fewer produced durable structural change. What makes this announcement notable is that CMS appears to be pushing beyond limited experimentation and toward broader operational scale.
That matters because the central challenge in American healthcare has never been a shortage of ideas. It has been the inability to implement them consistently across a fragmented system shaped by incompatible incentives, uneven provider capabilities, and persistent disparities in access and outcomes.
At its core, ACCESS reflects the next phase of accountable care. It builds on the Accountable Care Organization (ACO) model, but with a sharper focus on equity, community health and the practical realities of serving historically underserved populations.
This is an important correction. Earlier value-based care efforts often rewarded organizations that already had the infrastructure, capital and patient mix to perform well. Safety-net providers and organizations serving more complex populations were frequently asked to compete under rules that did not fully account for the social and structural barriers affecting their patients.
The ACCESS model suggests CMS is trying to address that imbalance. By bringing in a large and diverse cohort, the agency is effectively saying that accountable care must work not only in well-resourced systems, but in the real America of healthcare delivery: fragmented, unequal and operationally messy.
|
Track |
Qualifying Conditions |
Outcome-Aligned Payment Measures |
|---|---|---|
| eCKM | Hypertension, OR two or more of: dyslipidemia, obesity/overweight with central obesity, prediabetes | Control or minimum improvement in BP, lipids, weight and HbA1c |
| CKM | One or more of: diabetes mellitus, CKD, ASCVD | Control or minimum improvement in BP, lipids, weight and HbA1c; [CKD and diabetes only] Submission of eGFR and uACR data |
| MSK | Chronic musculoskeletal pain | Minimum improvement in pain intensity, interference and overall function (assessed via validated PROM) |
| BH | One or more of: depression, anxiety | Minimum improvement in symptoms (PHQ-9 for depression, GAD-7 for anxiety); Submission of PGIC at end of period; WHODAS 2.0 12-item functional assessment (optional in Year 1) |
ASCVD = atherosclerotic cardiovascular disease; BP = blood pressure; CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; GAD-7 = Generalized Anxiety Disorder-7; HbA1c = hemoglobin A1C; PGIC = Patient Global Impression of Change; PHQ-9 = Patient Health Questionnaire-9; PROM = patient-reported outcome measure; uACR = urine albumin-creatinine ratio; WHODAS = World Health Organization Disability Assessment Schedule 2.0.
Modified from Centers for Medicare & Medicaid Services. CMS ACCESS Technical Frequently Asked Questions. CMS.gov. Published March 18, 2026. Accessed September 11, 2026. https://equently-asked-questions.
To learn more, access key points and next steps on the following topic:
Reference:
About this series
This series is made possible in partnership with ALYKA Health (Digital Health Partner), which was named among the first 150 organizations selected to participate in the CMS ACCESS Model and is the first MedAxiom partner to do so.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.